Chronic stress is one of the most damaging forces in modern biology, quietly eroding health in everything from laboratory mice to livestock packed into intensive farming operations. Now, a team of researchers at Yangzhou University has reported that a humble molecule produced naturally in the gut, butyrate, may act as a powerful shield against that damage. In a study published in the journal Stress Biology, the scientists showed that oral supplementation with sodium butyrate, the mineral salt form of this short-chain fatty acid, prevented lipid metabolism disorders and intestinal injury in mice subjected to chronic corticosterone exposure, a widely used model of sustained physiological stress.
The research grew out of an earlier investigation into yellow-feather broilers, in which the team had observed that chronic stress dramatically reduced levels of butyric acid in the cecum, the pouch at the junction of the small and large intestines. Butyrate is generated there by fiber-fermenting bacteria, including genera such as Faecalibacterium, Roseburia, Butyricicoccus, and Eubacterium, and it serves as the primary energy source for the cells lining the colon. When the researchers noticed that these core butyrate-producing bacteria were significantly depleted in stressed birds, a logical question followed: if stress strips the gut of butyrate, could simply supplying it back protect the animal?
To answer that question, the team designed a two-pronged study. In the in vivo arm, sixty healthy male C57BL/6 mice were divided into three groups. A control group received water and saline injections, a stress group received daily intraperitoneal injections of corticosterone at 20 milligrams per kilogram of body weight for two weeks, and a combined group received the same corticosterone regimen alongside daily oral sodium butyrate at 200 milligrams per kilogram, begun two weeks before the stress protocol to establish a preventive intervention. In parallel, the researchers exposed IEC-6 cells, a rat small intestinal epithelial cell line, to 400 micromolar corticosterone, a concentration that reduced cell viability to roughly half, with or without 1 millimolar sodium butyrate.
The behavioral results were striking. In the Novelty-Suppressed Feeding Test, which measures anxiety-like behavior by timing how long a fasted mouse takes to begin eating in an unfamiliar arena, corticosterone-treated mice showed dramatically prolonged feeding latency. Sodium butyrate supplementation significantly shortened that latency, indicating a rescue of anxiety-like feeding behavior. In the Sucrose Preference Test, a classic measure of anhedonia, or the loss of pleasure, stressed mice showed markedly reduced interest in sweetened water, and while butyrate-treated animals displayed only a recovery trend rather than a statistically significant reversal, the authors note this pattern is consistent with prior reports that butyrate analogs preferentially improve anxiety-related behaviors over mood-related ones.
Beyond behavior, the metabolic consequences of chronic stress were substantial, and butyrate blunted many of them. Corticosterone exposure drove significant weight loss and reduced food intake, yet the supplemented animals recovered body weight by the end of the four-week experiment, accompanied by moderate increases in feed intake. Blood biochemistry revealed that stressed mice had depressed serum glucose and alkaline phosphatase alongside elevated aspartate aminotransferase, a marker of cellular damage in the liver and other tissues. Sodium butyrate intervention significantly reduced serum alkaline phosphatase and low-density lipoprotein cholesterol, the so-called bad cholesterol that is recognized as the primary risk factor for atherosclerotic disease. The authors argue that the apparent reduction in high-density lipoprotein cholesterol in the treated group reflects the clearance of dysfunctional HDL particles, whose antioxidant and cholesterol-transport functions are impaired under sustained cortisol elevation, rather than a deterioration of lipid health.
Perhaps the most visually dramatic findings came from the intestine itself. Histological examination showed that chronic stress shortened and deformed the finger-like villi of the duodenum, jejunum, and ileum, thinned the cecal mucosa, and disrupted crypt architecture. Quantitative analysis confirmed significant reductions in duodenal villus height and ileal villus-to-crypt ratio, along with deepened duodenal crypts. Scanning electron microscopy laid bare the ultrastructural carnage: villi surfaces that were rough, locally broken, and severely damaged at their tips. In mice given sodium butyrate, the villi regained a broad, leaf-like shape with smooth, intact surfaces, and the key morphological parameters of villus height, crypt depth, and their ratio were effectively restored to near-normal values.
At the molecular level, the protective effect was accompanied by a coordinated rewiring of immune signaling and barrier function. Butyrate supplementation suppressed expression of the pro-inflammatory cytokines IL-12, TNF-alpha, and IL-4 in the ileum while boosting the anti-inflammatory mediators IL-10 and IL-6, a shift the authors interpret as context-dependent: in chronic inflammation, IL-6 can switch from a pro-inflammatory amplifier to a tissue-repair signal through differential receptor usage and downstream STAT3 signaling. Tight junction proteins, the molecular rivets that seal the gaps between epithelial cells, also responded. Claudin expression rose significantly in the duodenum, jejunum, and ileum, and zonula occludens-1, or ZO-1, was elevated in the ileum and cecum, with additional upward trends in Occludin, the stem cell marker Lgr5, and the mucus component MUC2.
The cell culture experiments added mechanistic depth and pointed to a previously underappreciated signaling node. Corticosterone impaired the migration of IEC-6 cells in scratch wound assays and pushed them toward apoptosis, as measured by flow cytometry, with corresponding shifts in the BAX and BCL2 gene families. Sodium butyrate reversed both defects. Crucially, the stress hormone upregulated IL-12 and downregulated LRP5, a receptor involved in Wnt signaling that supports epithelial renewal, and butyrate co-treatment normalized both. The authors highlight this IL-12 and LRP5 crosstalk as a novel candidate mechanism, one that had not emerged from earlier butyrate studies focused narrowly on tight junctions or classical apoptosis genes, while cautioning that the high in vitro corticosterone concentration may partly reflect cytotoxic injury and should be extrapolated to living animals with care.
Finally, 16S rRNA sequencing of cecal contents revealed that chronic stress reshaped the microbial ecosystem in ways that went beyond simple diversity counts. Stressed mice showed increased richness and diversity indices but reduced community evenness, a pattern the authors interpret as ecological instability driven by opportunistic pathogens rather than a sign of a healthy gut. Stress-enriched taxa included members of Proteobacteria such as Gammaproteobacteria and Aeromonadaceae, while beneficial groups like Bifidobacterium were depleted. Sodium butyrate shifted the community back toward a control-like profile, significantly enriching the phylum Desulfobacterota, which contains butyrate-producing sulfate-reducing bacteria, and suppressing Proteobacteria and the genus Enterorhabdus. Functional prediction tools suggested the treated microbiota moved away from disease-associated pathways toward core metabolism, membrane transport, and energy processing. Taken together, the findings position sodium butyrate as a candidate environmentally friendly alternative to antibiotics for protecting livestock from stress, and as a possible prophylactic strategy for any animal, human included, facing chronic stress exposure, though the authors emphasize that future work with physiological corticosterone doses and direct metabolite measurements will be needed to confirm the IL-12 and LRP5 axis in vivo.
Subject of Research: Protective effects of oral sodium butyrate supplementation against chronic corticosterone-induced stress in mice
Article Title: Oral supplementation of sodium butyrate prevents lipid metabolism disorders and intestinal injury by modulating immunity, intestinal barrier functions, and gut microbiota in a corticosterone-induced chronic stress model in mice
Article References: Li, F., Wang, L., Cheng, J., Pan, S., & Lu, Y. (2026). Oral supplementation of sodium butyrate prevents lipid metabolism disorders and intestinal injury by modulating immunity, intestinal barrier functions, and gut microbiota in a corticosterone-induced chronic stress model in mice. Stress Biology, 6(1), Article 25. https://doi.org/10.1007/s44154-026-00289-2
Image Credits: AI Generated
DOI: 10.1007/s44154-026-00289-2
Keywords: sodium butyrate, chronic stress, corticosterone, gut microbiota, intestinal barrier, lipid metabolism, short-chain fatty acids, IEC-6 cells, tight junctions, IL-12, LRP5, Desulfobacterota
Cite Scienmag News
APA
MLA
Chicago
Morgan Morrow. (October 3, 2026). Gut Molecule Sodium Butyrate Shields Mice From Chronic Stress Damage. Scienmag. https://scienmag.com/gut-molecule-sodium-butyrate-shields-mice-from-chronic-stress-damage/
Morgan Morrow. “Gut Molecule Sodium Butyrate Shields Mice From Chronic Stress Damage.” Scienmag, 3 October 2026, https://scienmag.com/gut-molecule-sodium-butyrate-shields-mice-from-chronic-stress-damage/. Accessed 3 October 2026.
Morgan Morrow. “Gut Molecule Sodium Butyrate Shields Mice From Chronic Stress Damage.” Scienmag. October 3, 2026. https://scienmag.com/gut-molecule-sodium-butyrate-shields-mice-from-chronic-stress-damage/
Copy citation
Download RIS
Tags: animal stress modelschronic stresschronic stress protectioncorticosteroneDesulfobacterotadietary supplements for stressgut microbiotagut-brain axisIEC-6 cellsIL-12intestinal barrierintestinal healthlipid metabolismlipid metabolism regulationLRP5microbiome and stressmicrobiome-driven disease resistanceshort-chain fatty acidssodium butyratestress-induced gut injurytight junctions
